CD4 and bacterial infectious disease: WHO also recommends CTX prophylaxis for anybody with a CD4 count <350 cells/μl, or clinical stage 3 and 4 disease and irrespective of CD4 count or clinical stage in areas of high malaria prevalence and/or severe bacterial infections 22.